Vinicius Ernani, M.D.

  1. Oncologist

Location

  1. Phoenix, Arizona

Languages

EnglishPortugueseSpanish

Vinicius Ernani, M.D., is a thoracic medical oncologist at Mayo Clinic. He received his medical degree in Brazil, completed an internal medicine residency at the University of Miami/Jackson Memorial Hospital and a hematology and medical oncology fellowship at the Winship Cancer Institute of Emory University in Atlanta. Before joining Mayo Clinic, Dr. Ernani was an assistant professor at the Fred and Pamela Buffett Cancer Center/University of Nebraska and was an active member of the National Comprehensive Cancer Network (NCCN) guidelines. Dr. Ernani specializes in thoracic malignancies (lung, mesothelioma, and thymic) and is involved in developing and co-chairing clinical trials in lung cancer.

  1. 2016
    Fellowship - Hematology and Medical OncologyWinship Cancer Institute, Emory University School of Medicine
  2. 2013
    Internship/Residency - Internal MedicineMiller School of Medicine/Jackson Memorial Hospital, University of Miami
  3. 2008
    MDPontificia Universidade Catolica do Rio Grande do Sul (PUCRS)

Certifications

  1. 2016
    HematologyAmerican Board of Internal Medicine
  2. 2016
    Medical OncologyAmerican Board of Internal Medicine
  3. 2013
    Internal MedicineAmerican Board of Internal Medicine

Professional memberships

  1. 2021 - present
    MemberLung Cancer Disease Group Committee, Academic and Community Cancer Research United (ACCRU)
  2. 2019 - 2020
    MemberData Safety and Monitoring Committee (DSMC), University of Nebraska
  3. 2019 - 2020
    MemberMortality Review Committee, University of Nebraska
  4. 2019 - 2020
    MemberOccult Primary Guidelines Committee, National Comprehensive Cancer Network (NCCN)
  5. 2018 - 2020
    MemberInstitutional Review Board, University of Nebraska
  6. 2018 - present
    MemberCareer Development and Fellowship Committee, International Association for the Study of Lung Cancer (IASLC)
  7. 2015 - present
    MemberInternational Association for the Study of Lung Cancer (IASLC)
  8. 2013 - present
    MemberAmerican Society of Clinical Oncology

Publications